Literature DB >> 22307775

Polymorphisms in the VEGF-A in polypoidal choroidal vasculopathy in a Korean population.

Dong Ho Park1, In Taek Kim.   

Abstract

PURPOSE: The aim of this study was to investigate whether polymorphisms in the vascular endothelial growth factor A gene (VEGF-A) are associated with polypoidal choroidal vasculopathy (PCV) in a Korean population and whether they are associated with PCV phenotypes.
METHODS: This was a case-control study comprising 111 patients with PCV and 123 control participants. The PCV and control groups were genotyped for five polymorphisms in VEGF-A. Clinical characteristics were evaluated, including best-corrected visual acuity, fundus findings, and angiography findings at the first visit. Main outcome measures were the genotypes of variants and association with phenotypes.
RESULTS: Only rs833069 in VEGF-A generated significant allelic associations with PCV (P = 2.24 × 10(-5)). As compared with the AA group, the GG genotype group in rs833069 had a 6.25-fold increased risk of PCV [P = 7.45 × 10(-5), 95% confidence interval (CI) 2.52-15.46] and the AG group had a 1.82-fold increased risk (P = 0.029, 95% CI 1.03-3.24). The haplotype CCGC in VEGF-A showed an association with PCV (P = 2.90 × 10(-5)). However, the phenotypic characteristics of PCV did not show an association with the rs833069 genotypes.
CONCLUSIONS: The rs833069 polymorphism in VEGF-A was significantly associated with the risk of PCV in a Korean population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22307775     DOI: 10.1007/s10384-012-0119-6

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  28 in total

1.  Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranes.

Authors:  Olcay Tatar; Kei Shinoda; Annemarie Adam; Tillmann Eckert; Claus Eckardt; Klaus Lucke; Christoph Deuter; Karl Ulrich Bartz-Schmidt; Salvatore Grisanti
Journal:  Br J Ophthalmol       Date:  2006-09-20       Impact factor: 4.638

2.  Association of age-related macular degeneration with polymorphisms in vascular endothelial growth factor and its receptor.

Authors:  Alessandro Galan; Alberto Ferlin; Luigi Caretti; Genny Buson; Giovanni Sato; Anna Chiara Frigo; Carlo Foresta
Journal:  Ophthalmology       Date:  2010-05-14       Impact factor: 12.079

3.  Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction.

Authors:  P L Lip; A D Blann; M Hope-Ross; J M Gibson; G Y Lip
Journal:  Ophthalmology       Date:  2001-04       Impact factor: 12.079

4.  Increased expression of angiogenic growth factors in age-related maculopathy.

Authors:  M Kliffen; H S Sharma; C M Mooy; S Kerkvliet; P T de Jong
Journal:  Br J Ophthalmol       Date:  1997-02       Impact factor: 4.638

5.  Idiopathic polypoidal choroidal vasculopathy (IPCV).

Authors:  L A Yannuzzi; J Sorenson; R F Spaide; B Lipson
Journal:  Retina       Date:  1990       Impact factor: 4.256

6.  Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation.

Authors:  J A Wells; R Murthy; R Chibber; A Nunn; P A Molinatti; E M Kohner; Z J Gregor
Journal:  Br J Ophthalmol       Date:  1996-04       Impact factor: 4.638

7.  Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6.

Authors:  Jonathan L Haines; Nathalie Schnetz-Boutaud; Silke Schmidt; William K Scott; Anita Agarwal; Eric A Postel; Lana Olson; Shannon J Kenealy; Michael Hauser; John R Gilbert; Margaret A Pericak-Vance
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-01       Impact factor: 4.799

8.  Proper method for calculating average visual acuity.

Authors:  J T Holladay
Journal:  J Refract Surg       Date:  1997 Jul-Aug       Impact factor: 3.573

9.  Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy.

Authors:  R F Spaide; L A Yannuzzi; J S Slakter; J Sorenson; D A Orlach
Journal:  Retina       Date:  1995       Impact factor: 4.256

10.  Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results.

Authors:  Gregg T Kokame; Ling Yeung; James C Lai
Journal:  Br J Ophthalmol       Date:  2009-09-01       Impact factor: 4.638

View more
  2 in total

Review 1.  Association of PEDF polymorphisms with age-related macular degeneration and polypoidal choroidal vasculopathy: a systematic review and meta-analysis.

Authors:  Li Ma; Shu Min Tang; Shi Song Rong; Haoyu Chen; Alvin L Young; Govindasamy Kumaramanickavel; Chi Pui Pang; Li Jia Chen
Journal:  Sci Rep       Date:  2015-03-30       Impact factor: 4.379

2.  Pharmacogenetic association with early response to intravitreal ranibizumab for age-related macular degeneration in a Korean population.

Authors:  Woohyok Chang; Dong Hyoun Noh; Min Sagong; In Taek Kim
Journal:  Mol Vis       Date:  2013-03-21       Impact factor: 2.367

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.